The past few years have seen upheavals in healthcare, and 2024 so far shows no signs of breaking that pattern.
While the fundamentals of healthcare remain the same – caregivers treating patients – the who, how and where are changing, driven by shifting demographics, evolving consumer preferences, technological advancements and revolutionary drugs.
My work with clinicians in all 50 states, as well as the organizations that utilize their expertise, provides a unique lens to evaluate the
Read More
Philips Appoints Charlotte Hanneman as New CFO, Succeeding Abhijit Bhattacharya
What You Should Know:
- Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the appointment of Charlotte Hanneman as its new Chief Financial Officer (CFO).
- Ms. Hanneman will join the company's Board of Management on June 1, 2024, officially assuming the CFO role on October 1, 2024. She will succeed Abhijit Bhattacharya, who will retire on September 30, 2024, after a successful 37-year career with Philips.
Hanneman's Bio/Background
Ms. Hanneman brings
Read More
Redi Health Secures $14M to Transform Patient Support Programs
What You Should Know:
- Redi Health, an innovator in digital health solutions, announced today the successful closing of a $14 million Series B funding round.
- The Series B round, led by Blue Heron Capital, with participation from North Coast Ventures and existing investors, empowers Redi Health to accelerate growth and further establish itself as a leader in the digital health space.
Addressing Challenges in Patient Support Programs
Traditional Patient Support Programs (PSPs)
Read More
Absci Announces $75M Public Offering to Fuel AI Drug Creation
What You Should Know:
- Absci Corporation (Nasdaq: ABSI), a company utilizing generative AI for drug discovery, announced today an initial public offering (IPO) of $75 million in common stock.
- This IPO aims to support the advancement of Absci's internal drug development programs, further investment in their Integrated Drug Creation™ platform, and general corporate purposes.
Offering Details
Absci intends to offer $75M of common stock, with an option to sell an additional $11.25M
Read More
Veradigm Acquires ScienceIO for $140M in Cash to Accelerate AI Innovation in Healthcare
What You Should Know:
- Veradigm Inc. (NASDAQ: MDRX), a provider of healthcare data and technology solutions, announced an agreement to acquire ScienceIO, a leader in healthcare AI platform and foundation models.
- The acquisition is valued at $140 million in cash, with $44 million deferred and payable in installments over three years. Veradigm will fund the transaction entirely from existing cash reserves.
Strategic Acquisition to Enhance AI Capabilities
This acquisition signifies
Read More
Color Health, BCBS National Labor Office Partner to Empower Unions in the Fight Against Cancer
What You Should Know:
- Color Health, a leader in comprehensive cancer solutions, announced today a Strategic Alliance partnership with the Blue Cross Blue Shield (BCBS) National Labor Office (NLO).
- Through this alliance, Color Health and BCBS NLO aim to empower union leaders with the tools and resources needed to equip their members for the fight against cancer, promoting early detection, comprehensive care, and essential support services.
Comprehensive Cancer Care for Union
Read More
b.well Connected Health Secures $40M to Revolutionize Fragmented Healthcare Landscape
What You Should Know:
- b.well Connected Health, a leading platform provider for connected healthcare ecosystems raises $40M in Series C funding led by Leavitt Equity Partners.
- b.well’s FHIR-based platform empowers healthcare organizations to create a unified experience for consumers, allowing them to manage their health information, receive valuable insights, and access care services conveniently.
Expansion Plans
This Series C funding round further fuels b.well's mission to
Read More
Alamar Biosciences Raises $128M to Accelerate Proteomics Platform
What You Should Know:
- Alamar Biosciences, a leader in precision proteomics for early disease detection raises $100M in Series C round, with an additional $28M expected within the next 30 days. This brings their total funding to nearly $250M.
- The Series C funding round was led by led by Sands Capital, with participation from new and existing investors, including both financial and strategic partners. Ian Ratcliffe, Executive Managing Partner at Sands Capital, has joined Alamar's Board
Read More
Hello Heart Appoints Assaf Ohana as its First Chief Product Officer
What You Should Know:
- Hello Heart, a provider of innovative digital health solutions appoints Assaf Ohana as its inaugural Chief Product Officer.
- Prior to joining Hello Heart, Ohana served as Chief Product Officer at ActiveFence and Alto Pharmacy, where he played instrumental roles in developing cutting-edge products aimed at improving healthcare accessibility and efficiency. His extensive background in product leadership includes notable tenures at Instacart and Upwork, where he
Read More
Abridge Secures $150M to Expand GenAI, Partners with Yale New Haven Health System
What You Should Know:
- Abridge, the leading force in generative AI for clinical documentation, announced today a staggering $150 million Series C funding round led by Lightspeed Venture Partners. The funding also includes participation from new and existing investors like Redpoint Ventures, IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures, and
Read More
